Per cycle is not full-course cost
The number of cycles, treatment interval, dose, scans, port care, and response determine the complete bill.
Chemotherapy cost in Thailand
A per-cycle chemotherapy price is useful only when it identifies the cancer, regimen, drug names, dose method, cycle interval, expected number of cycles, pharmacy preparation, laboratory checks, anti-nausea treatment, port care, and what happens if a patient develops fever or needs admission. Thailand’s oncology hospitals can offer day-care and inpatient pathways, but international patients should confirm the medicine source, emergency capability, and whether the course can continue safely at home.
How much does chemotherapy cost in Thailand?
A standard outpatient chemotherapy administration in Thailand may be planned at THB 49,500 to 165,000 per cycle, approximately USD 1,500 to 5,000. A multi-cycle standard course may total THB 330,000 to 990,000, about USD 10,000 to 30,000. High-cost biologic combinations, inpatient protocols, intensive supportive care, or complications can reach THB 1,320,000 to 4,950,000+, roughly USD 40,000 to 150,000+. The drug, dose, weight, regimen, number of cycles, and hospital support determine the actual estimate.
USD illustrations use approximately THB 33 per USD, based on the Bank of Thailand exchange-rate context checked in July 2026. Drug and administration prices can change with brand, biosimilar, dose, body surface area, exchange rate, and stock. Confirm whether the quote is controlled in THB or another currency.
Share the basics and the Virello team will guide you toward the next step.
Prefer email? Write to support@virellohealth.com.
Reviewed 2026-07-19
Clinical review: Virello Health Clinical Content Team · Editorial review: Virello Health Research Team
Billing context: THB and USD
The number of cycles, treatment interval, dose, scans, port care, and response determine the complete bill.
Generic, originator, biosimilar, oral, infusion, weight-based, and body-surface-area dosing can produce very different prices.
CBC, kidney and liver results, infection review, and clinical assessment determine whether a cycle goes ahead.
Neutropenic fever may require urgent hospital assessment, antibiotics, cultures, admission, and a delayed cycle.
The team should explain drug access, cycle dates, scan timing, and how a home oncologist will receive the records.
Cost at a glance
The scenarios separate routine and complex pathways. They are not fixed packages and should be replaced by a report-led hospital estimate before travel.
| Scenario | THB | USD | Patient and treatment context | Planning scope |
|---|---|---|---|---|
| Standard day-care cycle | THB 49,500 - 165,000 | USD 1,500 - 5,000 | A stable patient receiving a defined generic cytotoxic regimen with pre-treatment blood testing and same-day observation. | State drug names, dose basis, administration, laboratory checks, antiemetics, chair time, nursing, and emergency contact. |
| Multi-cycle planned course | THB 330,000 - 990,000 | USD 10,000 - 30,000 | A curative, neoadjuvant, adjuvant, or disease-control plan spread over several cycles with response imaging. | Calculate cycle count, interval, dose changes, scans, port access, growth factors, and possible home-country continuation. |
| High-complexity or inpatient regimen | THB 1,320,000 - 4,950,000+ | USD 40,000 - 150,000+ | High-dose, multi-drug, inpatient, biologic-combination, marrow-suppressive, or complication-prone treatment. | Include isolation, blood products, antibiotics, ICU, prolonged admission, nutrition, and response-dependent additions. |
Usually included
Cancer diagnosis, stage, pathology, treatment intent, previous drugs, organ function, allergies, and cycle plan are reviewed.
Send the original protocol if available.
Drug preparation, infusion or injection, nursing, chair or room, premedication, and routine observation only as written.
Oral medicines and take-home drugs need separate wording.
CBC, kidney and liver tests, anti-nausea medicines, hydration, and other support included in the quotation.
Growth factors, transfusion, and port procedures may be separate.
Dose, date, adverse effects, next cycle, response scan, discharge record, and home-oncologist handover.
Ask for a complete treatment summary before departure.
Confirm separately
Dose escalation, extra cycle, originator switch, biologic addition, oral medicine, growth factor, or medicine for resistance.
Use a named drug and valid price period.
Neutropenic fever, sepsis, dehydration, organ injury, allergy, thrombosis, bleeding, mucositis, or ICU care.
Ask for inpatient and emergency rates.
Port insertion or removal, PICC care, transfusion, imaging, biopsy, specialist review, or hospital admission.
These can occur outside infusion day.
Flights, hotel, companion, transport, translation, local laboratory, home oncologist, medicines, and delayed return.
Keep a reserve for cycle changes.
Candidate context
Chemotherapy may be used before surgery, after surgery, with radiation, for blood cancers, for advanced disease, or as part of a combined regimen. The right drug sequence depends on pathology, stage, molecular findings, previous treatment, kidney and liver function, blood counts, heart function, neuropathy, hearing, fertility goals, pregnancy, infection risk, and the patient’s intent. A Thai oncologist should confirm the protocol and dose before an international patient travels. A low per-cycle number is not a safe substitute for a complete plan.
Histology, stage, receptor or molecular findings, and prior therapy must support the chosen regimen.
Kidney, liver, heart, hearing, nerves, blood counts, nutrition, and infection history influence drug choice and dose.
Neoadjuvant, adjuvant, curative, remission-focused, maintenance, or symptom-control intent changes duration and response assessment.
The patient needs a plan for fever, vomiting, diarrhea, rash, pain, blood counts, transfusion, and urgent admission.
Cycle dates, local oncologist, medicine availability, lab access, companion, accommodation, and flight flexibility should be settled.
Some localized cancers need local treatment before or instead of chemotherapy, depending on stage and biology.
A driver mutation may support an oral or infusion medicine that is more specific than conventional cytotoxic chemotherapy.
Immune treatment may be used alone or with chemotherapy in selected cancers after biomarker and indication review.
When disease control is the goal, symptom relief, transfusion, pain care, and quality of life may sit alongside or replace cytotoxic therapy.
Procedure variations
Technique, device, medicine, treatment extent, and prior care can change both the clinical plan and the estimate.
A same-day regimen is administered after blood tests and clinical review.
Chair time, premedication, hydration, and observation should be in the quote.
High-dose, continuous, multi-day, or complication-prone treatment requires admission and closer monitoring.
Ask about isolation, room, blood products, and ICU escalation.
Treatment before surgery aims to shrink disease or measure response.
Imaging and operation timing depend on response and blood recovery.
Postoperative treatment reduces recurrence risk for selected cancers.
Pathology and margin or node findings determine the plan.
Chemotherapy can be paired with targeted or immune treatment based on cancer type and biomarker.
Price every drug and administration line.
City comparison
Only cities with evidence for the procedure should appear here. A city range does not prove that every hospital in that city can manage the same case complexity.
| City | Local range | USD range | Capability context | Stay planning |
|---|---|---|---|---|
| Bangkok | THB 66,000 - 4,950,000+ | USD 2,000 - 150,000+ | Wide access to day-care oncology, inpatient protocols, molecular pharmacy, blood support, and clinical teams. | Confirm drug stock, infection admission, and home-country handover. |
| Chiang Mai | THB 59,400 - 4,290,000+ | USD 1,800 - 130,000+ | University and private services may provide planned cycles and selected complex care. | Ask about after-hours oncology and referral to Bangkok. |
| Phuket | THB 66,000 - 4,125,000+ | USD 2,000 - 125,000+ | International day-care services are accessible, while regimen depth and pharmacy supply vary. | Verify the oncology hospital rather than selecting a hotel location. |
| Pattaya and Chon Buri | THB 59,400 - 3,795,000+ | USD 1,800 - 115,000+ | Selected private and regional centers may support standard infusion and follow-up. | Confirm neutropenic fever admission and blood-product availability. |
| Khon Kaen | THB 56,100 - 3,630,000+ | USD 1,700 - 110,000+ | Regional tertiary care can suit planned protocols with specialist oversight. | Make pharmacy stock and laboratory timing part of the estimate. |
| Hat Yai and Songkhla | THB 56,100 - 3,630,000+ | USD 1,700 - 110,000+ | Southern services can offer selected day-care and inpatient oncology routes. | Ask how infection, dehydration, and reaction are handled overnight. |
| Nakhon Ratchasima | THB 52,800 - 3,300,000+ | USD 1,600 - 100,000+ | Large regional centers may provide value for stable cycles and follow-up. | Confirm the regimen, pharmacy, blood tests, and escalation link. |
| Chiang Rai | THB 52,800 - 3,135,000+ | USD 1,600 - 95,000+ | Selected regional infusion and monitoring may be available. | Verify emergency admission and transfer before beginning. |
| Udon Thani | THB 49,500 - 3,135,000+ | USD 1,500 - 95,000+ | Planned cycles and stable follow-up may suit a documented center. | Clarify language support, labs, drug availability, and weekend contact. |
| Rayong | THB 56,100 - 3,465,000+ | USD 1,700 - 105,000+ | Eastern corridor access can support selected outpatient pathways. | Do not choose a lower rate without a complete toxicity plan. |
Estimate variables
Generic, originator, biosimilar, body surface area, weight, infusion duration, and oral versus injectable route change the bill.
Require the exact regimen.
Curative courses, maintenance, progression, dose delay, scan response, and toxicity determine how long treatment continues.
Ask for low, expected, and extended scenarios.
Antiemetics, hydration, growth factors, antibiotics, transfusions, pain medicine, and port care can be substantial.
Name what is included.
Day-care, overnight observation, isolation, inpatient infusion, ICU, or home nursing have different rates.
Request daily overstay amounts.
Repeated flights, hotel, companion, local labs, interpreter, and home oncologist affect the complete treatment cost.
Medical and living budgets should be separate.
Medical cost breakdown
Pathology, stage, receptor or molecular results, previous protocol, treatment intent, and response imaging.
A Thai oncologist should confirm indication before drug purchase.
CBC, kidney and liver function, electrolytes, ECG or echo, infection review, pregnancy test, and examination when needed.
Old results may be repeated.
CT, MRI, PET, tumor markers, examination, and toxicity scoring at the schedule set by the cancer team.
Scans can change the plan.
Pharmacy preparation, infusion chair, nursing, premedication, hydration, observation, and discharge instructions.
Drug cost may be separate.
Room, daily blood tests, pump, nursing, specialist review, infection precautions, and supportive medicines.
Ask about isolation and ICU escalation.
Fever, allergy, dehydration, electrolyte disorder, bleeding, or organ toxicity assessment and admission.
This is rarely included in a standard cycle.
Blood counts, kidney and liver tests, fever plan, hydration, nutrition, nausea, bowel, nerve, and fatigue support.
The critical window may be after leaving day care.
Port insertion, dressing, flushing, infection assessment, PICC care, and removal when treatment ends.
Ask which access device is needed.
Prescription, local oncologist, laboratory, emergency hospital, scan dates, cycle delay rules, and medicine storage.
A home handoff prevents gaps.
Complete journey budget
Patient and attendant costs should be modeled separately from the medical estimate, with flexible dates and a contingency reserve.
Protocol, pathology, stage, prior drugs, labs, allergies, infection history, visa, insurance, and hospital acceptance.
Do not start with an unverified regimen.
Infusions, housing, companion, transport, meals, interpreter, local tests, medicines, and extra nights.
Fatigue and infection may require flexible arrangements.
Fit-to-fly, next-cycle date, home blood counts, fever contact, records, prescriptions, and response imaging.
Travel should follow clinical clearance.
Country access
Visa, donor, fertility, medicine, licensing, and treatment-access requirements can change. Confirm current rules with the relevant authority and treating hospital.
Confirm the hospital, oncology department, pharmacy, day-care or inpatient facility, and international coordination through current official information.
Ask for generic name, brand or biosimilar, Thai availability, approval or access route, stock, dose, and price validity.
The named hospital should explain fever, allergy, dehydration, bleeding, infection, organ injury, ICU, and blood-product support.
Agree protocol, dose, administration, laboratory, reaction, discharge, privacy, and handover documentation.
Check the Thailand e-Visa portal or relevant embassy and allow for cycle delay or hospital admission.
Hospital selection
Medical oncologist, pathology, radiology, pharmacist, nursing, and specialist input for the cancer type.
A coordinator should not replace the prescribing oncologist.
Verified prescription, pharmacy preparation, infusion pump, reaction response, extravasation protocol, and observation.
Ask who checks dose and body size.
CBC, cultures, antibiotics, transfusion, renal or liver support, pain, nutrition, and ICU access.
Match support to marrow suppression.
Drug, dose, administration, labs, premedication, cycle interval, number of cycles, scan, and overstay are separate.
Compare equal regimens.
Protocol, cumulative dose, reactions, next cycle, medicines, red flags, and home oncologist contact are supplied.
Keep records in English or a usable translation.
Treating team
Confirms diagnosis, treatment intent, regimen, dose, response criteria, toxicity, and whether treatment can continue at home.
Checks drug identity, dose, interaction, preparation, storage, infusion sequence, and medicine availability.
Administers treatment, observes reaction, teaches medicines, checks access, and explains the between-cycle warning plan.
Provide the tissue, biomarker, stage, and response information that supports the protocol.
Manages fever, dehydration, infection, pain, nutrition, transfusion, organ toxicity, and urgent admission.
Treatment timeline
Send pathology, stage, prior treatment, organ function, medicines, allergies, and the exact regimen if already prescribed.
The oncologist confirms indication, drug, dose, cycle interval, treatment intent, supportive care, and price assumptions.
Blood tests, examination, hydration, infection screen, access check, and medicine reconciliation occur before administration.
Pharmacy, nursing, infusion or inpatient protocol, monitoring, reaction response, and discharge teaching follow the plan.
The patient monitors fever, hydration, bowel, nausea, pain, mouth, nerve, and access symptoms with an urgent contact route.
The team records cumulative treatment, response scan, next cycle, delay rules, prescriptions, and home oncology communication.
Risks and edge cases
Fever after chemotherapy can indicate a dangerous infection and needs urgent blood tests, cultures, antibiotics, and admission.
Do not wait in a hotel.
Rash, wheeze, low blood pressure, chest tightness, or anaphylaxis can require treatment and a changed regimen.
Ask about emergency medicines.
Kidney, liver, heart, nerve, hearing, lung, or severe mucosal effects may need dose change or discontinuation.
Bring baseline tests.
Anemia, low platelets, transfusion, port infection, thrombosis, or extravasation can add admission and delay.
Confirm blood-bank access.
Low counts, infection, scan result, medicine stock, or travel problem can change the cycle schedule.
Use flexible flights and housing.
Cytotoxic drugs can affect pregnancy and reproductive function; counseling or preservation may be time-sensitive.
Discuss before starting therapy.
Destination comparison
The most suitable destination depends on the individual case, required team, treatment availability, travel route, legal eligibility, budget, and continuity after returning home.
| Decision factor | India | Turkey | Thailand | How to use this |
|---|---|---|---|---|
| Oncology access | Large oncology market with many day-care and value-city options. | Strong private and university oncology market with package variation. | International private and public tertiary hospitals offer day-care and inpatient cancer treatment. | Compare pharmacy, emergency, blood, ICU, and home continuity. |
| Price behavior | Per-cycle, drug brand, administration, and supportive care are often itemized separately. | Foreign-currency packages may obscure dose, cycles, or biosimilar assumptions. | THB cycle rates may exclude scans, admission, transfusion, and complications. | Request a full-course scenario. |
| Regional cycles | Stable day-care courses may fit Tier 2 cities under a specialist plan. | Regional centers may offer standard regimens after checking pharmacy and emergency support. | Regional care may fit selected stable cycles with tertiary backup. | Fever and drug access are decisive. |
| Travel continuity | Strong for South Asia, Gulf, and Africa. | Strong for Europe, Gulf, and Central Asia. | Strong for Southeast Asia and nearby Asian routes. | Choose the route with realistic return and local monitoring. |
Decision guidance
A named oncologist confirms the regimen, pharmacy identifies the medicine, emergency care is available, and the home handover is documented.
The quote shows only “one cycle,” hides brand or dose, excludes fever admission, or cannot provide the protocol and cumulative treatment record.
The case is stable, drug stock and laboratory support are confirmed, and a tertiary escalation route exists.
There is fever, severe breathlessness, uncontrolled vomiting, bleeding, confusion, shock, or a severe infusion reaction.
Reports for review
Prepare pathology, stage scans, the prescribed regimen, prior cycle dates and doses, blood counts, kidney and liver results, allergies, medicines, access-device details, infection history, and treatment goals. Ask the Thai hospital for a written course that names drug, dose, cycle count, administration, monitoring, supportive medicines, admission and emergency rates, THB validity, travel timing, and home handover.
Upload medical reportsInclude pathology, stage, receptor or molecular findings, treatment intent, and the reason chemotherapy is proposed.
Send drug names, doses, cycles, previous exposure, date of last treatment, response, and toxicity.
Provide CBC, kidney and liver function, electrolytes, ECG or echo, infection tests, and weight or body-surface information.
Document port, PICC, allergies, prior infusion reactions, transfusions, admissions, and difficult access.
Include diabetes, kidney, heart, lung, infection, nutrition, neuropathy, hearing, and fertility information.
List antiemetics, steroids, antibiotics, anticoagulants, supplements, and allergies.
Share passport, visa, companion, language, housing, insurance, transport, and flexible flight information.
Name oncologist, laboratory, emergency hospital, pharmacy, and caregiver.
Ask for generic and brand, dose, interval, cycle count, adjustment rules, and planned scans.
Confirm antiemetic, hydration, growth factor, port, transfusion, antibiotics, and fever response.
Request day-care, inpatient, isolation, ICU, and overstay rates.
Agree cumulative dose, reaction record, next cycle, red flags, prescription, privacy, and emergency terms.
Common questions
A standard day-care cycle may be THB 49,500 to 165,000, roughly USD 1,500 to 5,000, but the regimen, dose, drug, and support determine the actual cost.
A multi-cycle standard course may be THB 330,000 to 990,000, while high-cost or inpatient protocols can exceed THB 1,320,000.
It may or may not. Ask for the drug, dose, pharmacy preparation, administration, laboratory checks, supportive medicines, and observation separately.
Stable day-care care can be possible when the regimen, pharmacy, laboratory, emergency admission, and tertiary referral route are verified.
Contact the treating hospital urgently. Fever can be neutropenic infection and may need same-day blood tests, antibiotics, and admission.
Some oral cytotoxic or targeted medicines are systemic cancer treatment and still need prescription, monitoring, interactions, and supply planning.
The number depends on cancer type, intent, response, tolerance, and the protocol. The oncologist should provide an expected and change scenario.
Possibly, but blood counts, infection risk, symptoms, treatment timing, and the oncology team’s clearance determine safety.
Some regimens use a port or other access device. Ask whether insertion, care, infection, and removal are included.
Send pathology, regimen, prior doses, cycle dates, blood tests, organ function, allergies, medicines, access details, and complications.
Review and sources
The figures distinguish a standard outpatient cycle, a complete planned multi-cycle course, and high-complexity or inpatient treatment. The working conversion is approximately THB 33 per USD using the Bank of Thailand source checked in July 2026. The budget expands beyond the drug to laboratories, pharmacy preparation, access devices, supportive medicines, scans, infection, transfusion, hospital days, housing, and home monitoring. The oncologist and hospital pharmacy must provide the final regimen-specific estimate.
This page is educational and cannot prescribe chemotherapy, confirm a regimen, guarantee medicine availability, or certify a hospital’s current authorization. An oncologist should review the diagnosis, protocol, organ function, and prior treatment. Fever, severe breathlessness, bleeding, confusion, dehydration, or a serious infusion reaction requires urgent local medical care.
National Cancer Institute, Thailand · Accessed 2026-07-19
Supports: Cancer treatment context.
National Cancer Institute, Thailand · Accessed 2026-07-19
Supports: Cancer registry context.
National Cancer Institute, Thailand · Accessed 2026-07-19
Supports: Cancer burden context.
Bangkok Hospital · Accessed 2026-07-19
Supports: Thailand day-care, targeted, immune, and cancer-service context.
Thailand Medical Hub, Ministry of Public Health · Accessed 2026-07-19
Supports: Medical-service context.
Healthcare Accreditation Institute, Thailand · Accessed 2026-07-19
Supports: Quality context.
Bank of Thailand · Accessed 2026-07-19
Supports: Currency context.
Related planning
See how disease biology changes the total course.
Compare thoracic treatment and biomarker costs.
Review hormone and systemic care.
Compare neuro-oncology pathways.
Compare immune-drug treatment.
Compare India per-cycle and course ranges.
Compare another international route.
Prepare pathology and treatment records.
Request a regimen-matched estimate.
Plan home monitoring between cycles.
Questions about an estimate? Email support@virellohealth.com.